In PLoS ONE this week, University of Washington, Seattle, researchers report their identification of novel prognostic molecular features in acute myeloid leukemia, derived from their cross-study analyses of 25 gene expression profiling studies. One third of the 4,918 reported genes were replicated in more than one study, but only 9.6 percent of those repeated were associated with AML prognostics, the authors report.